Initiatives to Develop Compact and Multimodal Imaging Systems and High Prevalence of Chronic Diseases to Augment Growth of Life Science Microscopy Devices Market

Life Science Microscopy Devices Market


 Initiatives to develop compact and multimodal imaging systems is expected to propel growth of the global life science microscopy devices market. For instance, in December 2020, a new European research project called CARMEN announced its objective to improve the detection of cancerous cells during surgery. Under the project, the research institutes Laser Zentrum Hannover, Germany, and Multitel, Belgium are working with companies from both countries, JenLab, Deltatec, and LaserSpec, to develop a compact and multimodal imaging system.

High prevalence of chronic diseases is expected to offer lucrative growth opportunities for players in the global life science microscopy devices market. For instance, according to the study, “Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition”, published in the journal Diabetes Research and Clinical Practice, in September 2019, 463 million people are expected to suffer from diabetes in 2019 worldwide and the number is expected to reach 578 million by 2030 and 700 million by 2045.

High cost of microscopy devices is expected to limit growth of the life science microscopy devices market. For instance, Helios NanoLab Dual Beam SEM from FEI Company sells at US$ 2.2 million, Libra 200 TEM from Zeiss is priced at US$ 2.5 million, and Titan G2 80-200 scanning transmission electron microscope (S/TEM) at US$ 12.8 million. Moreover, product recalls are also expected to hinder growth of the market. For instance, in October 2019, Beckman Coulter Inc. recalled iQ200 Series Urine Microscopy Analyzer, owing to reported incidents where two sets of results report the same Specimen Identifier with different results, different Medical Record Number and different patient identification.

Among regions, North America is expected to witness significant growth in the life science microscopy devices market, owing to increasing prevalence of ocular disorders in the region. For instance, according to National Eye Institute’s projections, the number of people in the U.S. with cataract is expected to reach 50 million in 2050.

Competitive Analysis

Major players operating in the global life science microscopy devices market include, Olympus Corporation, Thermo fisher Scientific, Inc., Nikon Corporation, Carl Zeiss AG, Keyence Corporation, JEOL Ltd., Leica Microsystems, Bruker, Hitachi High-Technologies Corporation, Leica Microsystems, and F. Hoffman-La Roche Ltd.

Major players in the life science microscopy devices market are focused on adopting collaboration and partnership strategies to enhance their market share. For instance, in December 2019, Leica Microsystems collaborated with the European Molecular Biology Laboratory for the development of new imaging technologies.

Comments

Popular posts from this blog

Bourbon Whiskey Is the Most Popular Whiskey in America and In Many Other Countries around the World

Viral Vectors And Plasmid DNA Manufacturing Market Is Gaining Major Traction With Oxford Biomedica Plc Entering Into A 3-Year Agreement With Boehringer Ingelheim For The Manufacture And Supply Of Various Types Of Viral Vectors

Hard Surface Flooring Market Is Expected To Witness Robust Growth As Mohawk Industries Introduces Newly Imagined 30,000-Square Foot Floor Space At The International Surface Event (TISE)